What is the current Price Target for the Alto Neuroscience stock?

The average Alto Neuroscience target price is $37.74. This is 42.47% higher than the current stock price. The highest price target is 118.01%, the lowest is -0.87%. 11 Analysts have issued a price target Alto Neuroscience 2027 .

How high will the Alto Neuroscience stock rise?

No reliable answer can be given as to how high the Alto Neuroscience stock will rise. The performance of stocks, including the Alto Neuroscience stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Alto Neuroscience stock today?

The performance of Alto Neuroscience stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Alto Neuroscience stock fall?

The decline in Alto Neuroscience stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Alto Neuroscience Forecast, price target & analysts

$26.49

2.54%

NYSE, Sep 25, 04:00 pm EDT. Closed.

ISIN

US02157Q1094

Symbol

ANRO

Reports

Quarter | Annual

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Overview Analysts Charts Ownership News Strategies

Alto Neuroscience Target price 2026 - Analyst rating & recommendation

Alto Neuroscience Classifications & Recommendation

Buy

88%

Hold

12%

Alto Neuroscience Price Target

Target Price	$37.74
Price	$26.49
Potential	42.47% register free of charge
Number of Estimates	11

	11 Analysts have issued a price target Alto Neuroscience 2027 . The average Alto Neuroscience target price is $37.74. This is 42.47% register free of charge higher than the current stock price. The highest price target is $57.75 118.01% register free of charge , the lowest is $26.26 0.87% register free of charge .
	A rating was issued by 17 analysts: 15 Analysts recommend Alto Neuroscience to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Alto Neuroscience stock has an average upside potential 2027 of 42.47% register free of charge . Most analysts recommend the Alto Neuroscience stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '25	2026 Estimates
P/E		negative

13 Analysts have issued a Alto Neuroscience forecast for earnings per share. The average Alto Neuroscience EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2027	$-3.13 8.68% unlock
2028	$-3.11 0.64% unlock
2029	$-2.85 8.36% unlock
2030	$-0.96 66.32% unlock
2031	$3.51 465.63% unlock
2032	$8.90 153.56% unlock
2033	$11.65 30.90% unlock

Current	-13.52	804.76%
2026	-9.19 32.00% unlock
2027	-8.46 7.94% unlock
2028	-8.51 0.59% unlock
2029	-9.31 9.40% unlock
2030	-27.69 197.42% unlock
2031	7.56 127.30% unlock
2032	2.98 60.58% unlock
2033	2.27 23.83% unlock

Alto Neuroscience...

Current Alto Neuroscience Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 17 2026
BTIG	Locked ➜ Locked	Locked	Aug 13 2026
Wedbush	Locked ➜ Locked	Locked	Aug 13 2026
Baird	Locked ➜ Locked	Locked	May 18 2026
Wedbush	Locked ➜ Locked	Locked	May 14 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	May 11 2026
Chardan Capital	Locked ➜ Locked	Locked	Apr 22 2026

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 17 2026
Locked BTIG: Locked ➜ Locked	Aug 13 2026
Locked Wedbush: Locked ➜ Locked	Aug 13 2026
Locked Baird: Locked ➜ Locked	May 18 2026
Locked Wedbush: Locked ➜ Locked	May 14 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	May 11 2026
Locked Chardan Capital: Locked ➜ Locked	Apr 22 2026

Discover more stocks with a high price target

NIO ADR 104.57%

Alibaba Group Holding Ltd 70.15%

Rheinmetall 66.12%

Infineon 62.78%

Tencent Holdings Ltd. 56.53%

Adyen 53.79%

TUI 52.57%

Uber Technologies 47.97%

BYD 47.08%

Siemens Energy 46.63%

Adidas 42.38%

Deutsche Telekom 37.89%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now